Inventor · disambiguated record
Darren Robert Abbanat
Also filed as: ABBANAT DARREN · ABBANAT DARREN ROBERT
11 granted patents·3 pending applications·30 citations·filing 1993–2025
86Inventor score
Files withJANSSEN PHARMACEUTICALS INC8GLAXOSMITHKLINE BIOLOGICALS SA3WYETH CORP2AMERICAN CYANAMID CO1
Top patents by PatentIndex Score
14 records- 0193US10583185B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Mar 10, 2020·12 cites·20 claims
- 0292US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
- 0385US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
- 0478US6964860B2Glycopeptide antibioticsWYETH CORP·Filed 2002·Granted Nov 15, 2005·5 cites·89 claims
- 0577US12076385B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Sep 3, 2024·0 cites·22 claims
- 0676US12233121B2Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Feb 25, 2025·0 cites·8 claims
- 0772US2024316172A1Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0866US2025222093A1Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0965US11484582B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Nov 1, 2022·0 cites·20 claims
- 1064US11491220B2Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·0 cites·6 claims
- 1163US6914045B2Glycopeptide antibioticsWYETH CORP·Filed 2002·Granted Jul 5, 2005·2 cites·128 claims
- 1258US12233118B2Multivalent vaccine compositions and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Feb 25, 2025·0 cites·25 claims
- 1351US2025222088A1Multivalent vaccine compositions and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1429US5338729AAntibiotic 42D005 α and βAMERICAN CYANAMID CO·Filed 1993·Granted Aug 16, 1994·4 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Darren Robert Abbanat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →